eli lilly retatrutide trials ESC 2024: improves lipid and cardiovascular risk profile in Phase II trial Eli Lilly retatrutide Phase 3

The approach emphasized high protein intake (320g daily), strategic training with myo-rep giant sets, exactly 10,000 daily steps, and pharmaceutical support including tirzepatide for appetite and visceral fat management

Stratification by baseline nutritional status (e.g., selenium or iodine repletion) would clarify which populations benefit most

That local connection has a practical angle for patients: Lilly's LillyDirect self-pay program sells brand Zepbound vials directly for $299 to $449 per month depending on dose, bypassing traditional pharmacy markups

It transports the long-chain free fatty acids into mitochondria for -oxidation